Effects of oral rehydration solution-based prophylactic sodium supplementation on clinical outcomes in pediatric pneumonia: A randomized controlled trial

Table 4 Impact of oral rehydration solution supplementation on hospital outcomes in both groups, n (%)

	Interventional (n = 70)	Control (n = 70)	P value
Na on day 2 (mmol/L)
Median (IQR)	135 (3)	136 (5)	0.7951
Min-Max	131-150	127-143
Na on day 4 (mmol/L)
Median (IQR)	135 (3)	135 (5)	0.4131
Min-Max	129-145	127-148
Na on discharge (mmol/L)
Median (IQR)	137 (3)	135 (4)	0.0021,a
Min-Max	132-141	128-148
K on day 2 (mmol/L)
Mean (SD)	4.7 (0.7)	4.8 (0.7)	0.3722
Min-Max	3.1-6.5	3.4-6.2
K on day 4 (mmol/L)
Median (IQR)	4.9 (1.2)	5.0 (1.2)	0.4691
Min-Max	3.3-6.0	3.2-6.4
K on discharge (mmol/L)
Median (IQR)	4.9 (0.8)	4.8 (1.0)	0.7371
Min-Max	3.5-6.1	2.5-6.0
Modified shock index on day 4
Median (IQR)	1.8 (0.3)	1.8 (0.3)	0.6911
Min-Max	1.2-2.5	1.3-2.4
Respiratory score on day 4
Median (IQR)	4 (2)	6 (4)	0.0011,a
Min-Max	2-12	2-12
Modified shock index on discharge
Median (IQR)	1.8 (0.4)	1.6 (0.4)	0.2951
Min-Max	1.2-2.7	1.2-2.5
Fasting time (hours)
Mean (SD)	23.1 (11.5)	28.2 (12.2)	0.0122,a
Min-Max	6-48	6-48
NLR
Median (IQR)	1.0 (0.5)	0.9 (1.2)	0.9951
Min-Max	0.1- 3.7	0.1- 12
PNI
Median (IQR)	58.7 (17.9)	58 (12.6)	0.6861
Min-Max	29.5-102	39.5-96
PLR
Median (IQR)	92.0 (79.7)	84.4 (69.8)	0.2451
Min-Max	18-548	11.9-301.7

¹Mann-Whitney U test.

²Independent t test.

^aP values less than 0.05 were considered significant.

IQR: Interquartile range; K: Potassium; Min: Minimum; Max: Maximum; Na: Sodium; NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; PNI: Prognostic Nutritional Index.